Heart Rate Parasympathetic Nervous System
Conditions
Interventions
This is a simple-blind randomized crossover clinical trial. Twenty-four healthy individuals will undergo three types of stimulation with at least a one-week interval between sessions: Conventional Sti
Sponsors
Universidade Federal de São Paulo
Universidade Federal de São Paulo
Eligibility
Age
18 Years to 40 Years
Inclusion criteria
Inclusion criteria: Healthy volunteers; aged between 18 and 40 years; man ou woman; current or former undergraduate or graduate student of the Institute of Science and Technology at the Federal University of São Paulo
Exclusion criteria
Exclusion criteria: Volunteers with cardiovascular comorbidities; use of medications that interfere with autonomic control (beta-blockers, anxiolytics, and antidepressants) within the 6 months prior to participation
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Expected to observe stronger effects on cardiac autonomic control in healthy subjects with feedback-based transcutaneous auricular vagus nerve stimulation using the prototype developed by the research group, compared to transcutaneous auricular vagus nerve stimulation without feedback using a commercial device, based on the application of signal processing techniques. | — |
Secondary
| Measure | Time frame |
|---|---|
| Expected to observe a greater reduction in salivary cortisol levels in healthy subjects with feedback-based transcutaneous auricular vagus nerve stimulation using the prototype developed by the research group, compared to transcutaneous auricular vagus nerve stimulation without feedback using a commercial device. | — |
Countries
BR
Contacts
Public ContactTatiana Uchiyama
Universidade Federal de São Paulo
Outcome results
None listed